Early Pregnancy Plasma Per- and Polyfluoroalkyl Substances (PFAS) and Maternal Midlife Adiposity
Select PFAS, assessed in pregnancy, may differentially affect maternal midlife adiposity, influencing later-life maternal cardiometabolic health.
Authors
- Sheryl L. Rifas‐Shiman (ORCID: https://orcid.org/0000-0003-0033-920X)
- Briana Stephenson (ORCID: https://orcid.org/0000-0002-6147-1039)
- Emma V. Preston (ORCID: https://orcid.org/0000-0001-6685-0604)
- Marie‐France Hivert (ORCID: https://orcid.org/0000-0001-7752-2585)
- Shruthi Mahalingaiah (ORCID: https://orcid.org/0000-0002-5527-5787)
- Ami R. Zota (ORCID: https://orcid.org/0000-0003-0710-354X)
- Tamarra James‐Todd (ORCID: https://orcid.org/0000-0003-3589-5169)
- Jorge E. Chavarro (ORCID: https://orcid.org/0000-0002-4436-9630)
- Antonia M. Calafat (ORCID: https://orcid.org/0000-0002-9796-7482)
- Jordan A. Burdeau
- Emily Oken
Institutions
- Centers for Disease Control and Prevention (US)
- Harvard University (US)
- Massachusetts General Hospital (US)
- National Center for Environmental Health (US)
- Cancer Research And Biostatistics (US)
- Harvard Pilgrim Health Care (US)
- Columbia University (US)
Publication Details
- Journal
- The Journal of Clinical Endocrinology & Metabolism
- Published
- 2024-09-05
- DOI
- https://doi.org/10.1210/clinem/dgae542
- Citations
- 3
- Primary Topic
- Per- and polyfluoroalkyl substances research
- Type
- article
- Field-Weighted Citation Impact
- 0.75
Funders
- National Institutes of Health